CYBERKNIFE SYSTEM

Liver Metastasis

Case History

AGE: 68-year-old
GENDER: Female

Medical History

Rectal adenocarcinoma diagnosed and treated one year ago: Neoadjuvant chemoradiotherapy, surgical resection, adjuvant chemotherapy

Follow-up PET-CT: solitary hypermetabolic lesion in the liver, measuring 2.9cm with no other lesion

Planning CT Images

Treatment Plan Images

Treatment Planning Highlights

Fractionation

45 Gy in 3 fractions

PTV(s) Volume

PTV, 34.44 cc

Dose Distributions

  • Prescription to the
    70.7% isodose line
  • Max. dose 63.7 Gy

Collimator

InCise™ MLC

Dose Calculation Algorithm

FSPB

New Conformality Index (nCI)

nCi = 1.11

Gradient Index (GI)

GI = 2.83

Protocol Used

ACC-HM-001.3

Treatment Delivery Information

Tracking Method

Synchrony® Fiducial with Respiratory Modelling

Total Delivery Time

32 minutes

Medical Affairs

Accuray Medical Affairs serves as your comprehensive resource hub for clinical evidence, and peer collaboration through our user community.

Services

Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.

Solutions

From robotic to helical radiation therapy delivery, we invent unique, market-changing solutions that are designed to deliver radiation treatments across a full spectrum of patient needs.

Treatment Centers

Radiosurgery

Adaptive Radiotherapy

What's New

Your go-to source for staying informed about our advancements.

Why Accuray

Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.